BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 12526306)

  • 21. Chimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus.
    Kang H; Qi Y; Wang H; Zheng X; Gao Y; Li N; Yang S; Xia X
    Viruses; 2015 Mar; 7(3):1134-52. PubMed ID: 25768031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancing comparative rabies DNA vaccine effectiveness through glycoprotein gene modifications.
    Osinubi MO; Wu X; Franka R; Niezgoda M; Nok AJ; Ogunkoya AB; Rupprecht CE
    Vaccine; 2009 Nov; 27(51):7214-8. PubMed ID: 19925956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virus neutralizing antibody response in mice and dogs with a bicistronic DNA vaccine encoding rabies virus glycoprotein and canine parvovirus VP2.
    Patial S; Chaturvedi VK; Rai A; Saini M; Chandra R; Saini Y; Gupta PK
    Vaccine; 2007 May; 25(20):4020-8. PubMed ID: 17391817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Construction and immunogenicity of a recombinant pseudotype baculovirus expressing the glycoprotein of rabies virus in mice.
    Huang H; Xiao S; Qin J; Jiang Y; Yang S; Li T; Gao Y; Li Z; Li T; Su X; Ruan Y; Xu F; Wang H; Chen H; Xia X
    Arch Virol; 2011 May; 156(5):753-8. PubMed ID: 21221673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental immunization of cats with a recombinant rabies-canine adenovirus vaccine elicits a long-lasting neutralizing antibody response against rabies.
    Hu RL; Liu Y; Zhang SF; Zhang F; Fooks AR
    Vaccine; 2007 Jul; 25(29):5301-7. PubMed ID: 17576027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. 1984.
    Wiktor TJ; MacFarlan RI; Reagan KJ; Dietzschold B; Curtis PJ; Wunner WH; Kieny MP; Lathe R; Lecocq JP; Mackett M
    Biotechnology; 1992; 24():508-12. PubMed ID: 1422063
    [No Abstract]   [Full Text] [Related]  

  • 27. Development of combined vaccines for rabies and immunocontraception.
    Wu X; Franka R; Svoboda P; Pohl J; Rupprecht CE
    Vaccine; 2009 Nov; 27(51):7202-9. PubMed ID: 19925954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The induction of protective immune response in mice vaccinated by recombinant avian adenovirus CELO expressing glycoprotein G of the rabies virus].
    Shmarov MM; Tutykhina IL; Logunov DIu; Verkhovskai LV; Nedosekov VV; Tsybanov SZh; Novikov BV; Narodnitskiĭ BS; Gintsburg AL
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (4):69-71. PubMed ID: 16941876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A synthetic peptide encompassing the G5 antigenic region of the rabies virus induces high avidity but poorly neutralizing antibody in immunized animals.
    Niederhäuser S; Bruegger D; Zahno ML; Vogt HR; Peterhans E; Zanoni R; Bertoni G
    Vaccine; 2008 Dec; 26(52):6749-53. PubMed ID: 18955098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the immunogenicity of two inactivated recombinant rabies viruses overexpressing the glycoprotein.
    Navid MT; Li Y; Zhou M; Cui M; Fu ZF; Tang L; Zhao L
    Arch Virol; 2016 Oct; 161(10):2863-70. PubMed ID: 27438075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety studies on an adenovirus recombinant vaccine for rabies (AdRG1.3-ONRAB) in target and non-target species.
    Knowles MK; Nadin-Davis SA; Sheen M; Rosatte R; Mueller R; Beresford A
    Vaccine; 2009 Nov; 27(47):6619-26. PubMed ID: 19698811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the protective efficacy between single and combination of recombinant adenoviruses expressing complete and truncated glycoprotein, and nucleoprotein of the pathogenic street rabies virus in mice.
    Kim HH; Yang DK; Nah JJ; Song JY; Cho IS
    Virol J; 2017 Jun; 14(1):122. PubMed ID: 28646885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune response to neonatal genetic immunization.
    Wang Y; Xiang Z; Pasquini S; Ertl HC
    Virology; 1997 Feb; 228(2):278-84. PubMed ID: 9123835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective efficacy in mice of post-exposure vaccination with vaccinia virus recombinant expressing either rabies virus glycoprotein or nucleoprotein.
    Fujii H; Takita-Sonoda Y; Mifune K; Hirai K; Nishizono A; Mannen K
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1339-44. PubMed ID: 8207400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A recombinant rabies vaccine expressing the trimeric form of the glycoprotein confers enhanced immunogenicity and protection in outbred mice.
    Koraka P; Bosch BJ; Cox M; Chubet R; Amerongen Gv; Lövgren-Bengtsson K; Martina BE; Roose J; Rottier PJ; Osterhaus AD
    Vaccine; 2014 Aug; 32(36):4644-50. PubMed ID: 24962755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poly(lactide-co-glycolide) microspheres: a potent oral delivery system to elicit systemic immune response against inactivated rabies virus.
    Ramya R; Verma PC; Chaturvedi VK; Gupta PK; Pandey KD; Madhanmohan M; Kannaki TR; Sridevi R; Anukumar B
    Vaccine; 2009 Mar; 27(15):2138-43. PubMed ID: 19356617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A chimpanzee-origin adenovirus vector expressing the rabies virus glycoprotein as an oral vaccine against inhalation infection with rabies virus.
    Zhou D; Cun A; Li Y; Xiang Z; Ertl HC
    Mol Ther; 2006 Nov; 14(5):662-72. PubMed ID: 16797238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Canine adenoviruses elicit both humoral and cell-mediated immune responses against rabies following immunisation of sheep.
    Bouet-Cararo C; Contreras V; Fournier A; Jallet C; Guibert JM; Dubois E; Thiery R; Bréard E; Tordo N; Richardson J; Schwartz-Cornil I; Zientara S; Klonjkowski B
    Vaccine; 2011 Feb; 29(6):1304-10. PubMed ID: 21134446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of an E1-deleted, replication-defective adenovirus recombinant expressing the rabies virus glycoprotein for early vaccination of mice against rabies virus.
    Wang Y; Xiang Z; Pasquini S; Ertl HC
    J Virol; 1997 May; 71(5):3677-83. PubMed ID: 9094641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rabies DNA vaccine encoding lysosome-targeted glycoprotein supplemented with Emulsigen-D confers complete protection in preexposure and postexposure studies in BALB/c mice.
    Kaur M; Saxena A; Rai A; Bhatnagar R
    FASEB J; 2010 Jan; 24(1):173-83. PubMed ID: 19741168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.